Fundraising Fox
Mark Sullivan
InvestorVenture Partner at Adjuvant Capital
Melbourne, Australia
Writes $100K – $5M checks · typically $1.5M
Find your path to Mark
Sign up to see every warm intro you have to Mark
- Paths you didn't know you had: your email and LinkedIn already hold routes to Mark. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Mark Sullivan has 11 years of executive management, advisory, and board experience in biotechnology, along with 28 years in clinical development spanning biotech, large pharmaceutical, contract services, and academic settings. He has led project development of five biopharmaceutical products, the most recent of which received FDA approval in June 2018. At GHIF he led the team that brought the moxidectin program through late-stage development to FDA approval as a new treatment for onchocerciasis.
Invests in
Biotech
Colleagues at Adjuvant Capital
Network1
Investors connected to Mark in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Mark Sullivan?
- Mark Sullivan has 11 years of executive management, advisory, and board experience in biotechnology, along with 28 years in clinical development spanning biotech, large pharmaceutical, contract services, and academic settings. He has led project development of five biopharmaceutical products, the most recent of which received FDA approval in June 2018. At GHIF he led the team that brought the moxidectin program through late-stage development to FDA approval as a new treatment for onchocerciasis.
- Where does Mark Sullivan work?
- Mark Sullivan is Venture Partner at Adjuvant Capital.
- What does Mark Sullivan invest in?
- Mark Sullivan invests in Biotech.
- What check size does Mark Sullivan write?
- Mark Sullivan typically writes checks of $100K – $5M.
About this profile. Compiled from public sources — Adjuvant Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights